Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Cash from Financing Activities (2016 - 2025)

Skinvisible's Cash from Financing Activities history spans 15 years, with the latest figure at $34780.0 for Q1 2025.

  • For Q1 2025, Cash from Financing Activities rose 78.36% year-over-year to $34780.0; the TTM value through Sep 2025 reached $61416.0, down 6.75%, while the annual FY2024 figure was $88500.0, 1375.0% up from the prior year.
  • Cash from Financing Activities for Q1 2025 was $34780.0 at Skinvisible, up from $26636.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $36200.0 in Q2 2024 and bottomed at -$137000.0 in Q4 2021.
  • The 4-year median for Cash from Financing Activities is $5082.0 (2023), against an average of -$19632.0.
  • The largest annual shift saw Cash from Financing Activities plummeted 18400.0% in 2021 before it skyrocketed 565.9% in 2024.
  • A 4-year view of Cash from Financing Activities shows it stood at -$137000.0 in 2021, then surged by 102.92% to $4000.0 in 2023, then surged by 565.9% to $26636.0 in 2024, then skyrocketed by 30.58% to $34780.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Cash from Financing Activities are $34780.0 (Q1 2025), $26636.0 (Q4 2024), and $6164.0 (Q3 2024).